Stephen C. West

Last updated

Stephen West
Stephen C. West.jpg
Stephen West
Born (1952-04-11) 11 April 1952 (age 72)
Hessle, England, United Kingdom
NationalityBritish
Awards FRS (1995)
FMedSci (2000)
Royal Medal (2022)
American Academy of Arts and Sciences (2021)
National Academy of Sciences (2016)
Louis-Jeantet Prize for Medicine (2007) [1]
The Genetics Society Medal (2012)
Cancer Research UK Lifetime Achievement Prize (2018)
Scientific career
FieldsDNA recombination and repair
Institutions Francis Crick Institute

Yale University

Newcastle University

Stephen Craig West FRS (born 11 April 1952) is a British biochemist and molecular biologist specialising in research on DNA recombination and repair. He is known for pioneering studies on genome instability diseases including cancer. West obtained his BSc in 1974, and his PhD in 1977, both from Newcastle University. He is currently a Principal Group Leader at the Francis Crick Institute in London. He is an honorary Professor at University College London, and at Imperial College London. In recognition of his work he was awarded the Louis-Jeantet Prize for Medicine in 2007, is a fellow of the Royal Society, the Academy of Medical Sciences, an International Member of the National Academy of Sciences, and an International Honorary Member of the American Academy of Arts and Sciences. He received the 2022 Royal Medal for 'discovering and determining the functions of key enzymes that are essential for DNA recombination, repair and the maintenance of genomes'.

Contents

Early life and education

Stephen West was born on 11 April 1952 in Hessle, Yorkshire, to Joseph Clair West, a fishbuyer, and Louise West. Although he came from a working-class background, he did well enough at his local school (Hessle High School) to go to Newcastle University where he studied Biochemistry. He graduated with a BSc in 1974, and stayed in Newcastle to complete his PhD in 1977. His thesis advisor was Peter Emmerson.

Career

During his PhD work, he became interested in how cells recombine their DNA and use recombination for DNA repair. In 1977, he identified ‘protein X’ as the elusive RecA protein, which is essential for recombination and repair in bacteria. After finishing his PhD, which he completed within three years, he moved to the United States to join the group led by Paul Howard-Flanders, one of the early pioneers in the field of DNA repair. In 1985, West moved back to the United Kingdom and established his own group at the Imperial Cancer Research Fund's laboratories in South Mimms in Hertfordshire, which subsequently became known as Cancer Research UK. His colleagues at Clare Hall laboratory included the Nobel Prize winners Tim Hunt and Tomas Lindahl. In 2016, his laboratory moved to the new Francis Crick Institute in London.

Research

Highlights of research

In the Howard-Flanders group at Yale University, West purified and characterised RecA protein, and in doing so discovered many key aspects relating to the way that cells mediate DNA-DNA interactions and strand exchange. Parallel studies were carried out in the groups of Charles Radding (also at Yale University) and Robert Lehman (Stanford University). These three laboratories provided the groundwork for our current understanding of the enzymatic mechanisms of recombination.

After moving to the UK in 1985, West continued his work in bacterial systems, and set about trying to identify cellular proteins capable of resolving recombination intermediates. He identified RuvC as the first cellular enzyme that resolves recombination intermediates and characterised how this nuclease cuts Holliday junctions. He was also the first to show that RuvA and RuvB are motor proteins that mediate Holliday junction branch migration. His biochemical studies were compounded by genetic work from the laboratory of Robert Lloyd (University of Nottingham).

West’s laboratory then moved into eukaryotic systems, where he discovered eukaryotic Holliday junction resolvases (yeast Yen1 and human GEN1). The identification of GEN1 was the culmination of 18 years of research, and opened up the field to allow a genetic analysis of the pathways by which recombination intermediates are processed. Present understanding indicates that there are three distinct pathways of Holliday junction processing in human cells involving BLM-topoIIIα-RMI1-RMI2 (BTR), SLX1-SLX4-MUS81-EME1-ERCC1-XPF (SMX) and GEN1. His laboratory discovered that the Holliday junction resolvase activities of MUS81 and GEN1 are regulated so that they act late in the cell cycle to ensure chromosome segregation.

In addition to the discovery of cellular Holliday junction resolvases, West was the first to purify the human RAD51 protein (the eukaryotic ortholog of RecA), and to show that it promotes homologous pairing and strand exchange reactions similar to those mediated by RecA. In addition, he purified and then visualised the BRCA2 breast cancer tumour suppressor, showing that it acts as a molecular chaperone for the association RAD51 with DNA. His laboratory also discovered that Aprataxin, which is defective in a progressive neurological disorder known as Oculomotor apraxia, is a 5'-deadenylase that removes AMP from 5'-termini following abortive DNA ligation.

Recently his laboratory described the high resolution structure of the RAD51B-RAD51C-RAD51D-XRCC2 (BCDX2) complex using cryo-electron microscopy, and defined its function in DNA repair and tumour avoidance. He also used cryo-EM and biochemistry to determine the mechanism of single strand DNA annealing by the RAD52 protein.

As it is clear that DNA repair plays a critical role in the maintenance of genome stability and cancer avoidance, West’s work is significant in terms of understanding the molecular basis of human disease. In particular his laboratory discovered that loss of a nucleotide pool scavenger known as DNPH1 sensitises cancer cells to olaparib, a drug that is currently in use in the clinic for the treatment of breast, ovarian and prostate cancers caused by inheritable mutations in BRCA1 or BRCA2. He is in great demand as an international speaker, and gives several keynote lectures each year as a fine communicator of the intricacies of DNA recombination and repair.

Other professional activities

West has been on the editorial boards of a number of journals including e-Life (2014-2016), EMBO Journal (1996-2020) and EMBO Reports (2000-2022). He is currently on the editorial board of DNA Repair.

He has been a member of the Scientific Advisory Board of the Leibniz Institute on Aging, Fritz Lippman Institute, Jena, Germany, and is currently on the SABs of the Center for Chromosome Instability, University of Copenhagen, Denmark, the China Medical University (Taiwan), the Guangdong Key Laboratory of Genome Stability in Shenzhen, China, and the Max Planck Institute for Biochemistry, Martinsreid, Germany.

Steve currently serves on the Council of the Royal Society until 2027.

He is a serial conference organiser, having organised (or co-organised) more than 30 conferences throughout his career. For many years he has organised the biennial International Conference on ‘Mechanisms of Recombination’. The next meeting in the series will take place in Crete, Greece, in May 2025 and is supported by Fusion.

Honours and awards

West has been recognised on a number of occasions for his research:

Publications

West has published over 270 papers which have been cited more than 40,000 times. He has a H-index of 118.

Related Research Articles

<span class="mw-page-title-main">Chromosomal crossover</span> Cellular process

Chromosomal crossover, or crossing over, is the exchange of genetic material during sexual reproduction between two homologous chromosomes' non-sister chromatids that results in recombinant chromosomes. It is one of the final phases of genetic recombination, which occurs in the pachytene stage of prophase I of meiosis during a process called synapsis. Synapsis begins before the synaptonemal complex develops and is not completed until near the end of prophase I. Crossover usually occurs when matching regions on matching chromosomes break and then reconnect to the other chromosome.

<span class="mw-page-title-main">RuvABC</span> Protein complex

RuvABC is a complex of three proteins that mediate branch migration and resolve the Holliday junction created during homologous recombination in bacteria. As such, RuvABC is critical to bacterial DNA repair.

<span class="mw-page-title-main">Homologous recombination</span> Genetic recombination between identical or highly similar strands of genetic material

Homologous recombination is a type of genetic recombination in which genetic information is exchanged between two similar or identical molecules of double-stranded or single-stranded nucleic acids.

Cre-Lox recombination is a site-specific recombinase technology, used to carry out deletions, insertions, translocations and inversions at specific sites in the DNA of cells. It allows the DNA modification to be targeted to a specific cell type or be triggered by a specific external stimulus. It is implemented both in eukaryotic and prokaryotic systems. The Cre-lox recombination system has been particularly useful to help neuroscientists to study the brain in which complex cell types and neural circuits come together to generate cognition and behaviors. NIH Blueprint for Neuroscience Research has created several hundreds of Cre driver mouse lines which are currently used by the worldwide neuroscience community.

<span class="mw-page-title-main">Holliday junction</span> Branched nucleic acid structure

A Holliday junction is a branched nucleic acid structure that contains four double-stranded arms joined. These arms may adopt one of several conformations depending on buffer salt concentrations and the sequence of nucleobases closest to the junction. The structure is named after Robin Holliday, the molecular biologist who proposed its existence in 1964.

Recombinases are genetic recombination enzymes.

Robin Holliday was a British molecular biologist. Holliday described a mechanism of DNA-strand exchange that attempted to explain gene-conversion events that occur during meiosis in fungi. That model first proposed in 1964 and is now known as the Holliday Junction.

<span class="mw-page-title-main">EME1</span> Protein-coding gene in the species Homo sapiens

Crossover junction endonuclease EME1 is an enzyme that in humans is encoded by the EME1 gene. It forms a complex with MUS81 which resolves Holliday junctions. In mammalian cells the EME1/MUS81 protein complex is redundant for DNA damage repair with GEN1 endonuclease. In mice, EME1/MUS81 and GEN1 redundantly contribute to Holliday junction processing. When homozygous mutations of Gen1 and Eme1 were combined in mice the result was synthetic lethality at an early embryonic stage. Homozygosity for Gen1 mutations did not cause a DNA repair deficiency in mice. But when mice were both homozygous mutant for Gen1 and also heterozyous for an Emc1 mutation, they showed increased sensitivity to DNA damaging agents. This finding, indicated a redundant role of GEN1 and EME1 in DNA repair. Gen1 and Emc1 were also shown to have redundant roles in meiotic recombination.

<span class="mw-page-title-main">Branch migration</span>

Branch migration is the process by which base pairs on homologous DNA strands are consecutively exchanged at a Holliday junction, moving the branch point up or down the DNA sequence. Branch migration is the second step of genetic recombination, following the exchange of two single strands of DNA between two homologous chromosomes. The process is random, and the branch point can be displaced in either direction on the strand, influencing the degree of which the genetic material is exchanged. Branch migration can also be seen in DNA repair and replication, when filling in gaps in the sequence. It can also be seen when a foreign piece of DNA invades the strand.

<span class="mw-page-title-main">SLX4</span> Protein involved in DNA repair

SLX4 is a protein involved in DNA repair, where it has important roles in the final steps of homologous recombination. Mutations in the gene are associated with the disease Fanconi anemia.

Simon Joseph Boulton is a British scientist who has made important contributions to the understanding of DNA repair and the treatment of cancer resulting from DNA damage. He currently occupies the position of Senior Scientist and group leader of the DSB Repair Metabolism Laboratory at the Francis Crick Institute, London. He is also an honorary Professor at University College London.

Stephen Charles Kowalczykowski is a Distinguished Professor of Microbiology and Molecular Genetics at the University of California at Davis. His research focuses on the biochemistry and molecular biology of DNA repair and homologous recombination. His lab combines fluorescence microscopy, optical trapping and microfluidics to manipulate and visualize single molecules of DNA and the enzymes involved in processing and repairing DNA. He calls this scientific approach, "visual biochemistry". Stephen Kowalczykowski was elected to the American Society for Arts and Science in 2005, the National Academy of Sciences in 2007 and was a Harvey Society Lecturer at Rockefeller University in 2012.

Crossover junction endodeoxyribonuclease, also known as Holliday junction resolvase, Holliday junction endonuclease, Holliday junction-cleaving endonuclease, Holliday junction-resolving endoribonuclease, crossover junction endoribonuclease, and cruciform-cutting endonuclease, is an enzyme involved in DNA repair and homologous recombination. Specifically, it performs endonucleolytic cleavage that results in single-stranded crossover between two homologous DNA molecules at the Holliday junction to produce recombinant DNA products for chromosomal segregation. This process is known as Holliday junction resolution.

<span class="mw-page-title-main">Titia de Lange</span> Dutch geneticist

Titia de Lange is the Director of the Anderson Center for Cancer Research, the Leon Hess professor and the head of Laboratory Cell Biology and Genetics at Rockefeller University.

<span class="mw-page-title-main">SLX4IP</span> Protein-coding gene in the species Homo sapiens

SLX4 interacting protein is a protein that in humans is encoded by the SLX4IP gene.

Penelope "Penny" Jeggo is a noted British molecular biologist, best known for her work in understanding damage to DNA. She is also known for her work with DNA gene mutations. Her interest in DNA damage has inspired her to research radiation biology and radiation therapy and how radiation affects DNA. Jeggo has more than 170 publications that pertain to DNA damage, radiation, and cancer research and has received 3 top science awards/medals for her research. Jeggo has also been a member of several organizations that pertain to radiation biology; these organizations include Committee on Medical Aspects of Radiation in the Environment (COMARE), National Institute for Radiation Science laboratory researcher, and the Multidisciplinary European Low Dose Initiative (MELODI). Jeggo is a member of these organizations, and she is also an editor for several publication journals that are related to cancer and radiation biology. Jeggo is very passionate about her research and in an interview with Fiona Watt claimed that “Although my results contributed only the tiniest smidgeon to scientific knowledge, I gained immense satisfaction from it”.

Kalappa Muniyappa is an Indian molecular biologist and geneticist, known for his researches on the chromatization of DNA and gene targeting. He is a professor and chairman of the department of biochemistry of the Indian Institute of Science and an elected fellow of the Indian National Science Academy, Indian Academy of Sciences and the National Academy of Sciences, India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 1995, for his contributions to biological sciences.

<span class="mw-page-title-main">Cruciform DNA</span>

Cruciform DNA is a form of non-B DNA, or an alternative DNA structure. The formation of cruciform DNA requires the presence of palindromes called inverted repeat sequences. These inverted repeats contain a sequence of DNA in one strand that is repeated in the opposite direction on the other strand. As a result, inverted repeats are self-complementary and can give rise to structures such as hairpins and cruciforms. Cruciform DNA structures require at least a six nucleotide sequence of inverted repeats to form a structure consisting of a stem, branch point and loop in the shape of a cruciform, stabilized by negative DNA supercoiling.

<span class="mw-page-title-main">GEN1, Holliday junction 5' flap endonuclease</span> Protein-coding gene in the species Homo sapiens

GEN1, Holliday junction 5' flap endonuclease is a protein that in humans is encoded by the GEN1 gene.

John Francis Xavier Diffley is an American biochemist and Associate Research Director at the Francis Crick Institute. He is known for his contributions to the understanding of how DNA replication is initiated, and how it is subsequently regulated throughout the cell cycle and in response to DNA damage.

References

  1. Louis-Jeantet Prize
  2. "New Members 2021". American Academy of Arts & Sciences. Retrieved 23 April 2021.
  3. National Academy of Sciences Members and Foreign Associates Elected, News from the National Academy of Sciences, National Academy of Sciences, 3 May 2016, retrieved 14 May 2016.
  4. Louis-Jeantet Prize